<DOC>
	<DOC>NCT00225680</DOC>
	<brief_summary>This trial will compare the long term safety and effectiveness of the V Flex Plus PTX Drug Eluting coronary stent with conventional treatment for in-stent restenosis for coronary arteries.</brief_summary>
	<brief_title>In Stent ELUTES Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patient has given informed consent Patient has target lesion in native coronary artery or coronary bypass graft Patient has instent restenosis &gt;60% Patient has reference artery diameter 2.73.5 Patient agrees to return for clinical assessment at 1, 6, 9, 12 and 24 months and for a treadmill test at 9 months and an angiogram at 9 months and 24 months. Patient is less than 18 years of age Patient is pregnant or breast feeding Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions. Patient is simultaneously participating in another investigative interventional cardiovascular drug or device study. Patient has known hypersensitivity or contraindication to aspirin or stainless steel or a sensitivity to contrast agent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>coronary artery</keyword>
	<keyword>stent</keyword>
	<keyword>drug eluting</keyword>
	<keyword>patency</keyword>
	<keyword>restenosis</keyword>
</DOC>